These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 17911497)

  • 1. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure.
    Hernandez AF; Fonarow GC; Liang L; Al-Khatib SM; Curtis LH; LaBresh KA; Yancy CW; Albert NM; Peterson ED
    JAMA; 2007 Oct; 298(13):1525-32. PubMed ID: 17911497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in use of implantable cardioverter-defibrillator therapy among patients hospitalized for heart failure: have the previously observed sex and racial disparities changed over time?
    Al-Khatib SM; Hellkamp AS; Hernandez AF; Fonarow GC; Thomas KL; Al-Khalidi HR; Heidenreich PA; Hammill S; Yancy C; Peterson ED;
    Circulation; 2012 Mar; 125(9):1094-101. PubMed ID: 22287589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings from the Get With The Guidelines-Heart Failure Program.
    Hess PL; Hernandez AF; Bhatt DL; Hellkamp AS; Yancy CW; Schwamm LH; Peterson ED; Schulte PJ; Fonarow GC; Al-Khatib SM
    Circulation; 2016 Aug; 134(7):517-26. PubMed ID: 27492903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of Thomas KL; Al-Khatib SM; Kelsey RC; Bush H; Brosius L; Velazquez EJ; Peterson ED; Gilliam FR
    Am J Cardiol; 2007 Sep; 100(6):924-9. PubMed ID: 17826371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age differences in the use of implantable cardioverter-defibrillators among older patients hospitalized with heart failure.
    Hess PL; Grau-Sepulveda MV; Hernandez AF; Peterson ED; Bhatt DL; Schwamm LH; Yancy CW; Fonarow GC; Al-Khatib SM;
    J Cardiovasc Electrophysiol; 2013 Jun; 24(6):664-71. PubMed ID: 23437793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effectiveness of CRT and ICD therapy in heart failure patients by racial/ethnic classification: insights from the IMPROVE HF registry.
    Ziaeian B; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW; Fonarow GC
    J Am Coll Cardiol; 2014 Aug; 64(8):797-807. PubMed ID: 25145524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.
    Marzec LN; Peterson PN; Bao H; Curtis JP; Masoudi FA; Varosy PD; Bradley SM
    JAMA Cardiol; 2017 May; 2(5):561-565. PubMed ID: 28122073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent sex disparities in implantable cardioverter-defibrillator therapy.
    Johnson AE; Adhikari S; Althouse AD; Thoma F; Marroquin OC; Koscumb S; Hausmann LRM; Myaskovsky L; Saba SF
    Pacing Clin Electrophysiol; 2018 Sep; 41(9):1150-1157. PubMed ID: 29959781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction.
    LaPointe NM; Al-Khatib SM; Piccini JP; Atwater BD; Honeycutt E; Thomas K; Shah BR; Zimmer LO; Sanders G; Peterson ED
    Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):146-51. PubMed ID: 21304098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure.
    Chen CY; Stevenson LW; Stewart GC; Bhatt DL; Desai M; Seeger JD; Williams L; Jalbert JJ; Setoguchi S
    BMJ; 2015 Jul; 351():h3529. PubMed ID: 26174233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
    Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
    Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial and gender trends in the use of implantable cardioverter-defibrillators among Medicare beneficiaries between 1997 and 2003.
    Chan PS; Birkmeyer JD; Krumholz HM; Spertus JA; Nallamothu BK
    Congest Heart Fail; 2009; 15(2):51-7. PubMed ID: 19379450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Educational videos to reduce racial disparities in ICD therapy via innovative designs (VIVID): a randomized clinical trial.
    Thomas KL; Zimmer LO; Dai D; Al-Khatib SM; Allen LaPointe NM; Peterson ED
    Am Heart J; 2013 Jul; 166(1):157-63. PubMed ID: 23816035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease.
    Bansal N; Szpiro A; Reynolds K; Smith DH; Magid DJ; Gurwitz JH; Masoudi F; Greenlee RT; Tabada GH; Sung SH; Dighe A; Go AS
    JAMA Intern Med; 2018 Mar; 178(3):390-398. PubMed ID: 29404570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effectiveness of implantable cardioverter-defibrillators among medicare beneficiaries with heart failure.
    Hernandez AF; Fonarow GC; Hammill BG; Al-Khatib SM; Yancy CW; O'Connor CM; Schulman KA; Peterson ED; Curtis LH
    Circ Heart Fail; 2010 Jan; 3(1):7-13. PubMed ID: 20009044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prevention implantable cardioverter-defibrillators and survival in older women.
    Zeitler EP; Hellkamp AS; Fonarow GC; Hammill SC; Curtis LH; Hernandez AF; Al-Khalidi HR; Curtis JP; Heidenreich PA; Anstrom KJ; Peterson ED; Mark DB; Hammill BG; Sanders GD; Al-Khatib SM
    JACC Heart Fail; 2015 Feb; 3(2):159-67. PubMed ID: 25543969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF.
    Mehra MR; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride ML; O'Connor CM; Reynolds D; Walsh MN; Fonarow GC
    Heart Rhythm; 2009 Dec; 6(12):1727-34. PubMed ID: 19959119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death.
    Curtis LH; Al-Khatib SM; Shea AM; Hammill BG; Hernandez AF; Schulman KA
    JAMA; 2007 Oct; 298(13):1517-24. PubMed ID: 17911496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women and minorities are less likely to receive an implantable cardioverter defibrillator for primary prevention of sudden cardiac death.
    Mezu U; Ch I; Halder I; London B; Saba S
    Europace; 2012 Mar; 14(3):341-4. PubMed ID: 22071382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in African Americans undergoing cardioverter-defibrillator implantation for primary prevention of sudden cardiac death: findings from the Prospective Observational Study of Implantable Cardioverter-Defibrillators (PROSE-ICD).
    Zhang Y; Kennedy R; Blasco-Colmenares E; Butcher B; Norgard S; Eldadah Z; Dickfeld T; Ellenbogen KA; Marine JE; Guallar E; Tomaselli GF; Cheng A
    Heart Rhythm; 2014 Aug; 11(8):1377-83. PubMed ID: 24793459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.